The regulator's decision came after the company paused the study in September to review safety data following the deaths of ...

The clinical hold doesn’t cover its drug’s Investigational New Drug application for autoimmune hepatitis, for which the Phase ...

The FDA has placed Kezar Life Sciences’ lupus trial on hold after the biotech flagged four deaths during the phase 2b study.

The US FDA has imposed a clinical hold on Kezar Life Sciences’ IND application for zetomipzomib, aimed at treating lupus ...

Lupus (systemic lupus erythematosus) and multiple sclerosis can appear similar in many ways. Both lupus and MS are chronic autoimmune diseases. More than 100 different autoimmune diseases exist, with ...

Chronic kidney disease (CKD), sometimes called chronic kidney failure, means that kidneys are irreversibly damaged, and the ...

The FDA's decision comes after the company said it had paused the mid-stage trial of the drug, zetomipzomib, to review safety ...

Panelists discuss the goals of therapy for lupus nephritis (LN), emphasizing the urgency of treatment to prevent renal flares and the consequences of untreated LN, as well as strategies for ...

Panelists discuss the updated treatment recommendations for lupus nephritis in the Kidney Disease Improving Global Outcomes and European Alliance of Associations for Rheumatology guidelines ...

Fava said that the majority of patients with lupus nephritis don’t feel different than normal when they’re diagnosed and that the condition requires more aggressive treatment than for symptoms like ...

Lupkynis (voclosporin) is now approved in Japan to treat lupus nephritis, a complication of lupus marked by kidney damage and inflammation. The Japanese Ministry of Health, Labour, and Welfare ...